Direxion Daily S&P Biotech Bear 3X Shares LABD
Set alert
6.98 USD +0.23 +3.41%
At close · Oct 30
6.98 0.00 0.00%
After hours · Oct 30, 7:38 PM ET
6.50 Day range 7.20
5.90 52-week range 31.73
- YTD
- -66.86%
- 1 year
- -75.63%
- Open
- 6.88
- Prev close
- 6.75
- Mkt cap
- 15.43M
- Vol
- 23.03M
- Avg vol
- 20.60M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.50
- High
- 7.20
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.01
- 200-d avg
- 6.90
1Y chart
Events in this range
- Dec 23, 2025Dividend: 0.22872
- Mar 24, 2026Dividend: 0.08539
- Jun 23, 2026Dividend: 0.07523
- Sep 22, 2026Dividend: 0.07067
Signals (45)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 27, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| RSI: Oversold | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 13, 2026 | 3 months ago |
| RSI: Oversold | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 12, 2026 | 4 months ago |
| SMA: Bearish | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| SMA: Bullish | Jun 5, 2026 | 4 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 20, 2026 | 5 months ago |
| SMA: Bullish | May 19, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Mar 31, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 31, 2026 | 7 months ago |
| SMA: Bullish | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 25, 2026 | 7 months ago |
| SMA: Bullish | Mar 12, 2026 | 7 months ago |
| SMA: Bearish | Mar 9, 2026 | 7 months ago |
| SMA: Bullish | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Mar 3, 2026 | 8 months ago |
| MACD: Buy Signal | Mar 3, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| SMA: Bearish | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 22, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| RSI: Oversold | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 4, 2025 | 11 months ago |
| MACD: Buy Signal | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 24, 2025 | 11 months ago |
| RSI: Oversold | Nov 24, 2025 | 11 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 6.01
- 200-day average
- 6.90
About Direxion Daily S&P Biotech Bear 3X Shares
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
News
- EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks
- Heaps Of Healthy Health Care ETFs
- This Little Nugget Of An ETF Is Delivering Astounding Returns
- Leveraged ETF Rebalancing: It's Not As Bad As It Seems
- Wild Ride For Leveraged Biotech ETFs Continues
- Even With Recent Declines, Investors Still Love Biotech ETFs
Your note
Sign in to keep a note on LABD — it syncs with the Stock Master app.